Blackstone Inc’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-200,000
Closed -$3.87M 257
2022
Q1
$3.87M Buy
+200,000
New +$4.59M 0.01% 140
2020
Q4
Sell
-270,000
Closed -$15M 252
2020
Q3
$15M Buy
+270,000
New +$14.3M 0.06% 79

Other funds holding GDRX

Blackstone Inc's GDRX Position: Q2 2022 in Review

Blackstone Inc sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 200,000 shares — an estimated $3.87M sold.

Blackstone Inc first reported a position in GDRX in Q3 2020 and held it in 2 quarters. The position peaked at $15M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • Blackstone Inc reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • Blackstone Inc sold 200,000 GoodRx Holdings shares in Q2 2022, an estimated $3.87M.
  • Blackstone Inc first reported a position in GoodRx Holdings in Q3 2020 and held it in 2 quarters.
  • Blackstone Inc's GoodRx Holdings position peaked at $15M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Blackstone Inc's 13F filing for Q2 2022, filed 15 Aug 2022.